カテゴリ： GlobalData, ドイツ, 企業調査

Carl Zeiss Meditec AG (AFX)-医療機器分野：企業M&A・提携分析

◆英語タイトル：Carl Zeiss Meditec AG (AFX) - Medical Equipment - Deals and Alliances Profile
◆商品コード：DATA8011719
◆発行会社（調査会社）：GlobalData
◆発行日：2017年12月13日
◆ページ数：61
◆レポート言語：英語
◆レポート形式：PDF
◆納品方法：Eメール
◆対象地域：ドイツ
◆産業分野：医療機器
◆販売価格オプション（消費税別）
Single UserUSD250 ⇒換算￥37,000見積依頼/購入/質問フォーム
Site License（同一事業所内共有可）USD500 ⇒換算￥74,000見積依頼/購入/質問フォーム
Enterprisewide License（複数事業所内共有可）USD750 ⇒換算￥111,000見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※本体価格が￥30,000未満のレポートにつきましては、ハンドリングチャージ￥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
※GlobalData社の概要はこちらでご確認いただけます。

このエントリーをはてなブックマークに追加
LINEで送る


【レポートの概要】

Summary
Carl Zeiss Meditec AG (Carl Zeiss Meditec), a division of Carl Zeiss AG, an integrated medical technology company which operates in the fields of ophthalmology, neuro/ENT surgery and surgical ophthalmology. It provides comprehensive packages of solutions for the diagnosis and treatment of eye diseases including implants and consumable materials. Its major products include medical laser and diagnostic systems, intraocular lenses and consumables for ophthalmic surgery. The company products find application in diagnosis, monitoring and follow up treatment of various diseases of the eye diseases. The company products are marketed through distribution companies and agencies in Europe, the Americas and Asia-Pacific. Carl Zeiss Meditec is headquartered in Jena, Germany.

Carl Zeiss Meditec AG (AFX) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Carl Zeiss Meditec AG, Medical Equipment, Deals By Year, 2011 to YTD 2017 6
Carl Zeiss Meditec AG, Medical Equipment Deals By Type, 2011 to YTD 2017 7
Carl Zeiss Meditec AG, Medical Equipment, Deals By Region, 2011 to YTD 2017 8
Carl Zeiss Meditec AG, Medical Equipment, Deals By Market, 2011 to YTD 2017 9
Carl Zeiss Meditec AG, Medical Equipment, Deals Summary, 2011 to YTD 2017 10
Carl Zeiss Meditec AG, Medical Equipment, Deal Details 11
Asset Purchase 11
Valeant Pharma International May Sell Eye Surgery Assets to Carl Zeiss Meditec 11
Carl Zeiss Meditec Acquires Intraocular lens And Viscoelastic Devices Business From Imex Clinic, For US$23.2 Million 12
Partnerships 13
Abbott Medical Optics Enters into Distribution Agreement with Carl Zeiss Meditec 13
Carl Zeiss Meditec Enters Into Distribution Agreement With Henry Schein Dental 14
Equity Offering 15
Carl Zeiss Meditec Raises USD340 Million in Private Placement of Shares 15
Acquisition 16
Carl Zeiss Meditec Acquires Aaren Scientific For US$70 Million 16
Carl Zeiss Meditec Acquires Optronik 17
Carl Zeiss Receives Approval From European Commission To Acquire Remaining Stake In Carl Zeiss Vision 18
Carl Zeiss Meditec AG – Key Competitors 19
Carl Zeiss Meditec AG – Key Employees 20
Carl Zeiss Meditec AG – Locations And Subsidiaries 21
Head Office 21
Other Locations & Subsidiaries 21
Recent Developments 23
Strategy And Business Planning 23
Apr 25, 2017: ZEISS Opens New Microscopy Customer Center 23
Oct 26, 2016: ZEISS Invests Further 60 Million Euros in the Expansion of the Semiconductor Manufacturing Technology Factory 24
Financial Announcements 25
Dec 08, 2017: Carl Zeiss Meditec grows by 9% in fiscal year 2016/17 25
May 10, 2017: Carl Zeiss Meditec accelerates growth in the first six months of 2016/17 27
Apr 04, 2017: Carl Zeiss Meditec Group achieves first half 2016/17 revenue of approximately EUR 588 million 28
Feb 10, 2017: Carl Zeiss Meditec Off to A Solid Start Into Business Year 2016/17 29
Dec 09, 2016: Carl Zeiss Meditec continues its growth trend 30
Aug 12, 2016: Carl Zeiss Meditec Grows in Ophthalmology and Microsurgery 31
May 11, 2016: Carl Zeiss Meditec Records Revenue Growth of 8.6 Percent 32
Apr 29, 2016: ZEISS on Course to Further Growth 33
Apr 04, 2016: Carl Zeiss Meditec achieves revenue growth of approximately 9% in first half year 2015/16 34
Feb 12, 2016: Carl Zeiss Meditec Grows, Boosted by Currency Tailwinds / Strongest Growth Once Again in Surgical Ophthalmology 35
Feb 12, 2016: Carl Zeiss Meditec is again growing in the ophthalmology of the ophthalmology sector with a backwind of currency effects / strongest growth 36
Corporate Communications 38
Jun 29, 2017: New management for the ZEISS Consumer Optics division 38
May 08, 2017: ZEISS Appoints New Fellow 39
Oct 13, 2016: Carl Zeiss Meditec appoints Steven C. Schallhorn, MD as Chief Medical Officer 40
Jul 27, 2016: Carl Zeiss Meditec Recruits James V. Mazzo to Lead Its Newly Consolidated Ophthalmology Organization 41
Jul 20, 2016: Carl Zeiss Meditec announces change to Management Board 42
Legal and Regulatory 43
May 30, 2017: The German Court has Granted a Preliminary Injunction in Favour of VSY Biotechnology BV and Against Carl Zeiss Meditec 43
Mar 27, 2017: Carl Zeiss Meditec wins patent infringement action on trifocal intraocular lens against VSY Biotechnology and Fritz Ruck Ophthalmologische Systeme 44
Product News 45
Dec 04, 2017: New field emission scanning electron microscope ZEISS GeminiSEM 450 introduced 45
Nov 15, 2017: New 2D Superresolution mode for ZEISS Airyscan delivers 120 nanometer lateral resolution 46
Nov 11, 2017: ZEISS unveils digitalization and diagnostic advancements for eye care at AAO 2017 47
May 10, 2017: ZEISS is Presenting the SMILE Laser Correction, which Revitalises the US Market for Refractive Surgery, as well as the SWEPT Source Biometry with the Barrett Suite 49
May 08, 2017: At ASCRS 2017, ZEISS showcases SMILE laser vision correction, set to reinvigorate the US refractive surgery market, and SWEPT Source Biometry with the Barrett Suite for reducing the risk of refractive surprises 52
May 08, 2017: Open Innovation of ZEISS and the Advanced Retina Imaging Network advances Swept-Source OCT technology for better vision care 54
Oct 26, 2016: New ZEISS Axio Observer Microscopes for Life Science 55
May 03, 2016: ZEISS introduces Fast acquisition mode for ZEISS LSM 880 with Airyscan 56
Apr 29, 2016: ZEISS Receives CE Mark Approval for PLEX Elite 9000 Swept-Source OCT 57
02/09/2016: Zeiss AngioPlex Optical Coherence Tomography Angiography of the Retinal Microvasculature May Help Enhance Understanding of Retinal Disease 58
Other Significant Developments 59
Aug 07, 2017: Carl Zeiss Meditec continues its growth path 59
Appendix 61
Methodology 61
About GlobalData 61
Contact Us 61
Disclaimer 61

List of Tables
Carl Zeiss Meditec AG, Medical Equipment, Key Facts, 2016 2
Carl Zeiss Meditec AG, Medical Equipment, Deals Summary, 2011 to YTD 2017 2
Carl Zeiss Meditec AG, Medical Equipment, Deals By Year, 2011 to YTD 2017 6
Carl Zeiss Meditec AG, Medical Equipment Deals By Type, 2011 to YTD 2017 7
Carl Zeiss Meditec AG, Medical Equipment, Deals By Region, 2011 to YTD 2017 8
Carl Zeiss Meditec AG, Deals By Market, 2011 to YTD 2017 9
Carl Zeiss Meditec AG, Medical Equipment, Deals Summary, 2011 to YTD 2017 10
Valeant Pharma International May Sell Eye Surgery Assets to Carl Zeiss Meditec 11
Carl Zeiss Meditec Acquires Intraocular lens And Viscoelastic Devices Business From Imex Clinic, For US$23.2 Million 12
Abbott Medical Optics Enters into Distribution Agreement with Carl Zeiss Meditec 13
Carl Zeiss Meditec Enters Into Distribution Agreement With Henry Schein Dental 14
Carl Zeiss Meditec Raises USD340 Million in Private Placement of Shares 15
Carl Zeiss Meditec Acquires Aaren Scientific For US$70 Million 16
Carl Zeiss Meditec Acquires Optronik 17
Carl Zeiss Receives Approval From European Commission To Acquire Remaining Stake In Carl Zeiss Vision 18
Carl Zeiss Meditec AG, Key Competitors 19
Carl Zeiss Meditec AG, Key Employees 20
Carl Zeiss Meditec AG, Subsidiaries 21

★海外企業調査レポート[Carl Zeiss Meditec AG (AFX)-医療機器分野：企業M&A・提携分析]についてメールでお問い合わせはこちら
■おすすめ企業レポート■
  • BioTime Inc (BTX)-医療機器分野：企業M&A・提携分析
    Summary BioTime Inc (BioTime) is a biotechnology company which focuses on regenerative medicine and plasma volume expanders. The company’s Hextend is a blood plasma volume expander used for the treatment of hypovolemia in surgery, emergency trauma treatment, and other applications. It is also develo …
  • Galp Energia SGPS SA (GALP)：石油・ガス：M&Aディール及び事業提携情報
    Summary Galp Energia SGPS SA (Galp) is an integrated energy company. It explores for, develops and produces crude oil and natural gas, refines crude oil, and markets refined petroleum products. The company also conducts power generation, produces biodiesel and trades gas. It imports, transports and …
  • Pilgrim’s Pride Corporation：企業の戦略・SWOT・財務情報
    Pilgrim's Pride Corporation - Strategy, SWOT and Corporate Finance Report Summary Pilgrim's Pride Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Guangzhou Improve Medical Instruments Co Ltd (300030)：医療機器：M&Aディール及び事業提携情報
    Summary Guangzhou Improve Medical Instruments Co Ltd (Improve Medical) is a medical devices company that offers medical products, technologies, and services for clinical laboratory and clinical nursing. The company’s products include Improvacuter evacuated blood collection systems, Impromini capilla …
  • GE Healthcare LLC-製薬・医療分野：企業M&A・提携分析
    Summary GE Healthcare LLC (GE Healthcare) a business unit of General Electric Company, is a global medical device provider that designs, develops, manufactures, and distributes diagnostic imaging and clinical systems; products and services for drug discovery, biopharmaceutical manufacturing and cell …
  • BrightSpring Health Services：企業の戦略的SWOT分析
    BrightSpring Health Services - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produc …
  • Enerjisa Enerji Uretim AS：電力：M&Aディール及び事業提携情報
    Summary Enerjisa Enerji Uretim A.S. (Enerjisa Enerji), a subsidiary of Enerjisa Enerji A.S, is an energy utility. The company generates electricity from natural gas, lignite coal, hydro, and wind sources. It owns and operates wind plants such as Canakkale in Mahmudiye, Dagpazari in Mut, and Balikesi …
  • Sidi Kerir Petrochemicals Co (SKPC)：企業の財務・戦略的SWOT分析
    Summary Sidi Kerir Petrochemicals Co (Sidpec), a subsidiary of Egyptian Petrochemicals Holding Co, is a chemical company that manufactures and distributes petrochemical products. The company offers high density polyethylene and linear low density polyethylene which are used in plastic applications i …
  • Watchstone Group plc (WTG)：企業の財務・戦略的SWOT分析
    Summary Watchstone Group plc (Watchstone) formerly Quindell Plc, is a technology company that offers services such as software; consulting and technology enabled outsourcing services. The company provide solutions such as Hubio, pt Health, ingenie, InnoCare, QuoteSupermarket, and others. It provides …
  • Chemring Ordnance, Inc.：企業の戦略・SWOT・財務情報
    Chemring Ordnance, Inc. - Strategy, SWOT and Corporate Finance Report Summary Chemring Ordnance, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Mironid Ltd：製薬・医療：M&Aディール及び事業提携情報
    Summary Mironid Ltd (Mironid) is a drug discovery company that develops drug candidate molecules. The company offers drug candidate by modulating the activity of key cell signaling proteins for the treatment of degenerative kidney diseases, chronic inflammatory diseases, and cancer. Its drug discove …
  • Beazer Homes USA Inc：企業の戦略・SWOT・財務情報
    Beazer Homes USA Inc - Strategy, SWOT and Corporate Finance Report Summary Beazer Homes USA Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • CSL Limited：企業のM&A・事業提携・投資動向
    CSL Limited - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's CSL Limited Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, ca …
  • SurModics Inc (SRDX)-医療機器分野：企業M&A・提携分析
    Summary SurModics Inc (SurModics) is a provider of device drug delivery coating and in vitro diagnostic technologies. The company offers wide range of advanced technologies that includes medical device coating technologies and surface modification coating technologies. Its technologies are employed …
  • The Bangchak Petroleum PCL (BCP)：企業の財務・戦略的SWOT分析
    The Bangchak Petroleum PCL (BCP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Capsugel Inc：企業の戦略的SWOT分析
    Capsugel Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Energy Transfer Partners LP (ETP)：石油・ガス：M&Aディール及び事業提携情報
    Summary Energy Transfer Partners LP (ETP) is a master limited partnership. It owns and operates diversified portfolio of energy assets in the US. The partnership carries out the gathering, processing, storage, intra- and interstate transportation of natural gas and natural gas liquids. ETP also cond …
  • Infinera Corporation：戦略・SWOT・企業財務分析
    Infinera Corporation - Strategy, SWOT and Corporate Finance Report Summary Infinera Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • XBiotech Inc (XBIT)：製薬・医療：M&Aディール及び事業提携情報
    Summary XBiotech Inc (XBiotech) is a biopharmaceutical company that discovers, develops and commercialize therapeutic antibodies based proprietary technology. The company provides monoclonal antibodies treatment for various diseases. It’s lead product Xilonix, a therapeutic antibody being developed …
  • American Bio Medica Corp (ABMC)：企業の財務・戦略的SWOT分析
    Summary American Bio Medica Corp (ABMC) is a biotechnology company that develops, manufactures and markets immunoassay test kits. The company’s products include Rapid TOX, Rapid One, and Rapid Drug Screen, among others. It offers OralStat used for the detection of drugs in oral fluids. ABMC also pro …

◆H&Iグローバルリサーチ株式会社のお客様（例）◆